Menu
Back to Journals » Cancer Management and Research » Volume 14
Original Research
Efficacy of Osimertinib After Progression of First-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) in EGFR-Mutated Lung Adenocarcinoma: A Real-World Study in Chinese Patients
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 7,005 | Dovepress* | 6,550+ | 356 | 6,906 | |
| PubMed Central* | 455 | 159 | 614 | ||
| Totals | 7,005 | 515 | 7,520 | ||
| *Since 1 March 2022 | |||||
View citations on PubMed Central and Google Scholar